Navigation Links
National Business Coalition on Health Announces November 9-11 Annual Conference Speakers
Date:6/23/2008

WASHINGTON, June 23 /PRNewswire/ -- The National Business Coalition on Health (NBCH), a national, non-profit, membership organization of nearly 60 business and health coalitions, representing over 7,000 employers and 34 million employees and their dependents across the U.S., announced the lineup to date of confirmed speakers for its 13th Annual Conference being held in Washington, November 9-11, 2008. The conference The Employer Challenge: Connecting Health, Health Benefits & Business Strategies convenes business and health coalitions, employers and health care industry stakeholders from across the nation to share best practices and address value based purchasing strategies.

Confirmed speakers include:

- Craig Barrett, PhD, Chairman, Intel Corporation

- Gerald Shea, Assistant to the President of Governmental Affairs, AFL-CIO

- Karen Ignagni, President and CEO, America's Health Insurance Plans

- John Tooker, MD, MBA, FACP, Executive Vice President and CEO, American College of Physicians

- Richard Umbdenstock, President and CEO, American Hospital Association

- John Castellani, President, Business Roundtable

- Julie Gerberding, MD, Director, Centers for Disease Control and Prevention

- Mark McClellan, MD, PhD, Director, Engelberg Center for Health Care Reform, Brookings Institution

- Grace-Marie Turner, President, Galen Institute

- Susan Dentzer, Editor-in Chief, Health Affairs

- Paul Grundy, MD, MPH, FACOEM, FACPM, Director of Health Care, Technology & Strategic Initiatives, IBM

- Drew Altman, PhD, President and CEO, Kaiser Family Foundation

- Len Nichols, Director Health Policy Program, New America Foundation

- Debra Ness, President and CEO, Partnership for Women and Families

Conference awards

The conference will feature three award programs:

- The 2008 Value Based Purchasing Membership Award, sponsored by AstraZeneca, is given to an NB
'/>"/>

SOURCE National Business Coalition on Health
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Emile Hirsch Visits the Democratic Republic of Congo With International Aid Agency Oxfam
2. CIGNA HealthCare and VITAS Innovative Hospice Care Enter Into a National Agreement
3. Verizon Wireless Continues Support of National HIV Testing Awareness Campaign
4. Bruce Palsulich Joins Relsys International as Chief Innovation & Strategy Officer
5. Chiltern and EPS INTERNATIONAL Enter Into a Global Partnership
6. Religious Coalition for Reproductive Choice to Hold National Black Religious Summit on Sexuality
7. National Rehabilitation Hospital Team Calls Work of US Armys Europe Regional Medical Command Impressive
8. Family Health International Awarded USAID Progress Project to Improve Family Planning and Reproductive Health Programs in Developing Countries
9. Changes in local health care markets affect national patient safety project
10. uKarma Corporation Commences International Distribution Agreement With Northern Response for its Xflowsion DVD Series
11. LPA Hosts 51st National Conference in Detroit
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:National Ergonomics Expo Sees Immediate 93% Exhibit Space Renewal for 2010; Equipois, Herman Miller, Neutral Posture, REDpoint International Win 2009 Attendees' Choice New Product Awards 2Lentigen Awarded Phase I SBIR Grant for Hepatitis C Vaccine 2Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix 2Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix 3Baxa Corporation Releases IntelliFlowRx 28TM 29 Upgrades 49198 1Baxa Corporation Releases IntelliFlowRx 28TM 29 Upgrades 49198 2Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late Stage Leukaemia 12671 1Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late Stage Leukaemia 12671 2Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late Stage Leukaemia 12671 3Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late Stage Leukaemia 12671 4Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late Stage Leukaemia 12671 5Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late Stage Leukaemia 12671 6Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late Stage Leukaemia 12671 7Stroke Damage Is Less in Rats Given Opioids 49194 1